1-12 of 12
Feng-Ting Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel HDAC Inhibitor Chidamide Synergizes with Rituximab to Inhibit DLBCL Tumor Growth in Vitro and In Vivo By up-Regulating CD20 Expression

Xu-Wen Guan, MD, Wang Hua-Qing, MD PhD, Li Jia, MD PhD, Feng-Ting Liu, MB, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2947.
https://doi.org/10.1182/blood-2018-99-114598
Published: 2018
Journal Articles

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Li Jia, Andrew Clear, Feng-Ting Liu, Janet Matthews, Nadiha Uddin, Aine McCarthy, Elena Hoxha, Catherine Durance, Sameena Iqbal, John G. Gribben
Journal: Blood
Blood (2014) 123 (11): 1709–1719.
https://doi.org/10.1182/blood-2013-10-529610
Published: 2014
Includes: Supplemental data
Journal Articles

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal
Journal: Blood
Blood (2011) 118 (8): 2174–2183.
https://doi.org/10.1182/blood-2011-02-334326
Published: 2011
Includes: Supplemental data
Journal Articles

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal
Journal: Blood
Blood (2010) 115 (15): 3079–3088.
https://doi.org/10.1182/blood-2009-08-239483
Published: 2010
Includes: Supplemental data
Journal Articles

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

Feng-Ting Liu, MB, PhD, Li Jia, MB, PhD, Timothy Farren, BSc(HONS), MIBMS, Jerome Giustiniani, Armand Bensussan, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4372.
https://doi.org/10.1182/blood.V114.22.4372.4372
Published: 2009
Journal Articles

CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies.

Timothy W Farren, BSc(HONS), MIBMS, Feng-Ting Liu, MB, PhD, Claire Stephens, MSc, Dimitris Tsitsikas, MBBS, MRCP, Marion G Macey, PhD, FRCPath, Michael Jenner, MD, PhD, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4382.
https://doi.org/10.1182/blood.V114.22.4382.4382
Published: 2009
Journal Articles

Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death!.

Sami r G Agrawal, MD, PhD, Feng-Ting Liu, MB, PhD, Jerome Giustiniani, PhD, Li Jia, MB, PhD, John G. Gribben, MD, DSc, Armand Bensussan, PhD
Journal: Blood
Blood (2008) 112 (11): 2088.
https://doi.org/10.1182/blood.V112.11.2088.2088
Published: 2008
Journal Articles

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Feng-Ting Liu, Samir G. Agrawal, Zanyar Movasaghi, Peter B. Wyatt, Ihtesham U. Rehman, John G. Gribben, Adrian C. Newland, Li Jia
Journal: Blood
Blood (2008) 112 (9): 3835–3846.
https://doi.org/10.1182/blood-2008-04-150227
Published: 2008
Includes: Supplemental data
Journal Articles

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia

Samir G. Agrawal, Feng-Ting Liu, Catherine Wiseman, Sima Shirali, Hongxiang Liu, Debra Lillington, Ming-Qing Du, Denise Syndercombe-Court, Adrian C. Newland, John G. Gribben, Li Jia
Journal: Blood
Blood (2008) 111 (5): 2790–2796.
https://doi.org/10.1182/blood-2007-10-110460
Published: 2008
Journal Articles

Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL

Feng-Ting Liu, Samir G. Agrawal, John G. Gribben, Hongtao Ye, Ming-Qing Du, Adrian C. Newland, Li Jia
Journal: Blood
Blood (2008) 111 (5): 2797–2805.
https://doi.org/10.1182/blood-2007-08-110445
Published: 2008
Journal Articles

Bax Degradation Activity Is a Novel Poor Prognosis Marker of Chronic Lymphocytic Leukemia.

Samir G. Agrawal, MD, PhD, Feng-Ting Liu, MB, PhD, Catherine Wiseman, PhD, Sima Shirali, PhD, Hongxiang Liu, PhD, Debra Lillington, PhD, Ming Qing Du, MB, PhD, Denise Syndercombe Court, PhD, Adrian C. Newland, MD, John G. Gribben, MD, PhD, Li Jia, MB, PhD
Journal: Blood
Blood (2007) 110 (11): 3087.
https://doi.org/10.1182/blood.V110.11.3087.3087
Published: 2007
Journal Articles

Apaf-1 protein deficiency confers resistance to cytochrome c –dependent apoptosis in human leukemic cells

Li Jia, Srinivasa M. Srinivasula, Feng-Ting Liu, Adrian C. Newland, Teresa Fernandes-Alnemri, Emad S. Alnemri, Stephen M. Kelsey
Journal: Blood
Blood (2001) 98 (2): 414–421.
https://doi.org/10.1182/blood.V98.2.414
Published: 2001